Compare · LAWS vs TMO
LAWS vs TMO
Side-by-side comparison of Lawson Products Inc. (LAWS) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- LAWS operates in Capital Goods, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $175.70B, about 403.6x LAWS ($435.3M).
- TMO has hit the wire 17 times in the past 4 weeks while LAWS has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 0 for LAWS).
- Company
- Lawson Products Inc.
- Thermo Fisher Scientific Inc
- Price
- $40.88+0.25%
- $472.72+0.00%
- Market cap
- $435.3M
- $175.70B
- 1M return
- -
- -0.30%
- 1Y return
- -
- +15.77%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 0
- 17
- Recent ratings
- 0
- 25
Lawson Products Inc.
Lawson Products, Inc. distributes products and services to the industrial, commercial, institutional, and government maintenance, repair, and operations marketplace in the United States and Canada. It operates in two segments, Lawson and Bolt. The company's products include fastening systems, cutting tools and abrasives, fluid power products, specialty chemicals, electrical products, aftermarket automotive supplies, safety products, welding and metal repair products, and other products. It serves customers operating in the automotive repair, commercial vehicle maintenance, government, manufacturing, food processing, distribution, construction, oil and gas, mining, wholesale, service, and other industries. The company sells its products through sales representatives, as well as directly from its Website. Lawson Products, Inc. was incorporated in 1952 and is headquartered in Chicago, Illinois.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest LAWS
- Lawson Products Inc. and Green Boom Join Forces for a Sustainable Future
- SEC Form 4: Brown Matthew Jay exercised 778 shares at a strike of $36.86, increasing direct ownership by 25% to 3,911 units
- SEC Form 4: Pufpaf Richard D exercised 697 shares at a strike of $36.86, increasing direct ownership by 5% to 13,758 units
- SEC Form 4: Knutson Ronald J exercised 1,766 shares at a strike of $36.86 and covered exercise/tax liability with 747 shares, increasing direct ownership by 3% to 36,765 units
- SEC Form 4: Rhodes Bianca was granted 2,034 units of Common Stock - Restricted Stock Units
- SEC Form 4: Moon Mark F was granted 2,034 units of Common Stock - Restricted Stock Units
- SEC Form 4: Albert Andrew B was granted 2,034 units of Common Stock - Restricted Stock Units
- SEC Form 4: Hillman Lee S was granted 2,034 units of Common Stock - Restricted Stock Units
- SEC Form 4: Edelson I Steven was granted 2,034 units of Common Stock - Restricted Stock Units
- SEC Form 4: Zamarripa Robert was granted 2,034 units of Common Stock - Restricted Stock Units
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)